Third, beginning October 1, 2024, upon the expiration of device pass-through payment status for C1831, CMS packaged the payment for the costs of each of the devices described by C1831 into the payment for the costs related to the procedure with which each device is reported in the hospital claims data
In other words, this is not a miracle cure wrapped in a tiny vial
that broader claim is not well supported
Section 1833(t)(9)(A) of the Act also requires the Secretary to consult with an expert outside advisory panel composed of an appropriate selection of representatives of providers to review (and advise the Secretary concerning) the clinical integrity of the APC groups and the relative payment weights
Duki M, Radonji T, Jovanovi I, Zdravkovi M, Todorovi Z, Krainik N, et al
there are other alternatives